Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 493
Selected: 0
NCT IDTitle
NCT00061906Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer
NCT03892044Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma
NCT07216404Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
NCT02033928Comprehensive Frailty Assessment
NCT06396598Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer
NCT00569309Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
NCT00201747Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
NCT03409432Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma
NCT01219777Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
NCT02812693Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification
NCT00417976Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer
NCT04781088Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT02942524Checklist Tool in Engaging Patients in the Discharge Planning Process
NCT04602026The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer
NCT02186470Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer
NCT04597086Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients
NCT02268188Harvesting Health Program in Improving Diet and Physical Activity Level in Cancer Survivors
NCT05984888Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
NCT02077959Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT04329962Metabolism and Absorption of Anthocyanins From Extract and Whole Blueberry Powder Confections in Healthy Adults
NCT07111234Studying Flavors and Cooling Agents in Oral Nicotine Pouches to Understand User Preferences
NCT00456872Contrast of Buffered Vs. Unbuffered Lidocaine in Bone Marrow Biopsies
NCT05665725Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma
NCT02144649Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery
NCT00009932Combination Chemotherapy in Treating Patients With Solid Tumors
NCT03460483Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care
NCT07215988Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
NCT05674578Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors
NCT04780568Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer
NCT04411849Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia
NCT07455513A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer
NCT00729612Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
NCT01206777Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies
NCT01491958Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation
NCT02837887Computerized Cognitive Behavior Therapy in Treating Depression in Patients With Cancer
NCT02943642Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides
NCT04395274Young Adult EC Use and Respiratory Outcomes
NCT00003041Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer
NCT04164069Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
NCT01005758Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT04774068Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas
NCT02803333Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study
NCT05641831Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study
NCT01823549Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients
NCT03868423Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers
NCT01460940A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
NCT02125019Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer
NCT07166419Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia
NCT01521039Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease
NCT05234307PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer